Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hodgkin Disease × Fumigant 93 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Peripheral Nervous System Diseases 1 Multiple Myeloma 1 Hodgkin Disease 1 Disseminated Intravascular Coagulation 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Age Problem 1

Interventions

Cyclophosphamide 179 fludarabine phosphate 105 Etoposide 100 Peripheral Blood Stem Cell Transplantation 90 Filgrastim 82 Mycophenolic Acid 80 Doxorubicin 78 Whole-Body Irradiation 73 Melphalan 73 Radiotherapy 68 Brentuximab Vedotin 68 Tacrolimus 66 fludarabine 63 Busulfan 63 Vinblastine 59 Cyclosporine 58 Rituximab 56 Dacarbazine 49 Gemcitabine 48 Granulocyte Colony-Stimulating Factor 47 Bleomycin 47 Vincristine 43 Antilymphocyte Serum 43 Prednisone 41 Nivolumab 40 Cytarabine 40 Methotrexate 39 Carmustine 34 pembrolizumab 31 Sirolimus 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01858922 2024-01-12

TXCH-HD-12A

Baylor College of Medicine

Phase 2 Completed

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡